Arintra Secures $25 Million in Series B Funding for its Healthcare Revenue Assurance AI Platform

Arintra, a leading enterprise AI platform for revenue assurance in healthcare, has announced a significant achievement in the form of a $25 million Series B funding round. The total funding for the company now stands at $51 million, with Define Ventures leading the latest funding round. Notable existing investors such as Peak XV Partners, Yale New Haven Health (YNHH) Center for Health Care Innovation, Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Ten13, and Spider Capital also participated in the round.

The company's AI platform is being recognized for its pioneering approach to revenue assurance, offering a solution to the prevalent issue of inaccurate and delayed payments within the U.S. healthcare system. Arintra has garnered a strong client base, including prominent health systems and provider groups such as UC Davis Health, Mercyhealth, Meritus Health, Rochester Regional Health, Reid Health, and Mercy Medical Center, among others. The platform's capabilities have resulted in a 5.1% increase in compliant revenue capture, a 32% reduction in costs, and a 43% decrease in coding-related denials for its clients.

With the latest funding, Arintra plans to further expand its presence across enterprise health systems, enhance its clinical and specialty coverage, and extend the platform's reach within the revenue cycle. The company's investment in advancing its technology aligns with the growing financial pressures faced by health systems, emphasizing the critical need for effective revenue assurance solutions in the current healthcare landscape.